Advertisement

Synergy Technologies, Inc. Company Profile

13:32 EDT 19th June 2013 | BioPortfolio

Synergy Technologies, Inc. is a privately-held specialty chemical company offering a revolutionary line of antimicrobial products for the agricultural and food processing industries.. The firm has developed a number of food safety and animal health products that can be used to provide safe, non-toxic and economical solutions to fight harmful foodborne pathogens such as Salmonella, E.coli, Listeria and Campylobacter. The backbone of Synergy’s product line includes the SYNTRx® series of processing aids. For additional information, visit www.syntrx.net.


News Articles [ 193 Associated News Articles listed on BioPortfolio]

Synergy Pharmaceuticals: Synergy Pharmaceuticals Inc. Announces Public Offering of Common Stock

NEW YORK, 2013-04-09 22:37 CEST (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it is...

Synergy Pharmaceuticals: Synergy Pharmaceuticals Reports 2012 Fourth Quarter and Full-Year Financial Results

NEW YORK, 2013-03-18 22:00 CET (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financia...

Synergy Pharmaceuticals: Synergy Pharmaceuticals Files IND for SP-333, a Developmental Drug for Gastrointestinal Diseases

NEW YORK, 2012-09-12 14:35 CEST (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that...

Synergy Pharmaceuticals: Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results

NEW YORK, 2013-05-09 23:33 CEST (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financi...

Synergy Pharmaceuticals: Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock

NEW YORK, 2013-04-16 18:07 CEST (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc.(Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of it...

Synergy Pharmaceuticals: Synergy Pharmaceuticals Completes Phase I Trial of SP-333, a Second-Generation GC-C Agonist to Treat Gastrointestinal Diseases

NEW YORK, 2012-12-28 11:00 CET (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today the su...

Synergy Pharma and Callisto enter merger accord

USA-based biopharma groups Synergy Pharmaceuticals (Nasdaq: SGYP) and Callisto Pharmaceuticals (OTCBB: CLSP) entered into a definitive merger agreement pursuant to which Callisto will merge into Syner...

Synergy Pharmaceuticals: Synergy Pharmaceuticals Highlights Mechanistic Features of Plecanatide, a Novel Investigational Drug for Chronic Idiopathic Constipation

Scientific Poster Presentations This Week at ACG 2012 and UEG Week NEW YORK, 2012-10-22 23:00 CEST (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat ...

Drugs and Medications [ 4 Associated Drugs and Medications listed on BioPortfolio]

Endure 200 [Ecolab Inc.]

Drug Facts

Vinoperfect day perfecting spf 15 [Caudalie USA Inc.]

VINOPERFECT DAY PERFECTING CREAM SPF 15

Clarins self tanning milk with sun protection spf 6 [Laboratoires Clarins S.A.]

Clarins Self Tanning Milk With Sun Protection Spf 6

Pediaderm ta [Arbor Pharmaceuticals, Inc.]

Triamcinolone Acetonide Cream USP, 0.1%

PubMed Articles [ 106 Associated PubMed Articles listed on BioPortfolio]

Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.

We measured the inhibition of infectivity of HIV-1 isolates and derivative clones by combinations of neutralizing antibodies (NAbs) and other entry inhibitors in a single-cycle-replication assay. Syne...

Nerve and Behavioral Responses of Mice to Various Umami Substances.

Food contains various taste substances. Among them, umami substances play an important role with regard to the perception of the taste of food, but, few studies have examined the taste characteristics...

Closed-loop and open-loop control of posture and movement during human trunk bending.

Closed-loop (CL) and open-loop (OL) types of motor control during human forward upper trunk bending are investigated. A two-joint (hip and ankle) biomechanical model of the human body is used. The ana...

Interleukin-7 induced Stat-5 acts in synergy with Flt-3 signaling to stimulate expansion of hematopoietic progenitor cells.

The development of lymphoid cells from bone marrow progenitors is dictated by interplay between internal cues such as transcription factors and external signals like the cytokines Flt-3 ligand and Il-...

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Aims: The EVOLVE FHU trial demonstrated non-inferiority of six-month late loss with two dose formulations of SYNERGY, a novel bioabsorbable polymer everolimus-eluting stent (EES) compared with the dur...

Clinical Trials [ 27 Associated Clinical Trials listed on BioPortfolio]

Safety and Performance Evaluation of CircuLite Synergy

The purpose of the study is to demonstrate the safety and functionality of the CircuLite Synergy Pocket Circulatory Assist Device.

Single Centre Study to Compare Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer Breast Reconstruction

The purpose of this single centre study is to evaluate whether the use of Harmonic Synergy Dissecting Hook (Harmonic Scalpel) in breast reconstruction surgery is superior to conventional d...

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

Irinotecan has demonstrated activity in malignant gliomas in multiple phase II studies. The activity is limited, with an approximately 15 % response rate and a progression-free survival of...

Synbiotic Treatment in Crohn's Disease Patients

The purpose of this study is to determine whether administration of a synbiotic, comprised on inulin and a bifidobacterial probiotic will colonise the gut wall and down-regulate TNF-alpha...

Mini Stem Radiostereometric Analysis Study

The objectives of this study are to assess migration of the MIS Stem compared to the Synergy Hip System, and to assess the long-term safety and effectiveness of the study device using Radi...

Companies [ 46 Associated Companies listed on BioPortfolio]

Synergy Health Concepts

The team at Pacific Interventionalists launched Synergy Health Concepts to focus specifically on CCSVI treatment and care. Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) is c...

Synergy Pharmaceuticals, Inc.

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug SP-304 is a synthetic a...

Synergy Research Inc.

Synergy Research was found in 1997. It is a privately held company. Centrally located in Northern New Jersey. Synergy Research is all about bringing together the necessary talent and resources, combin...

Synergy Health and Fitness

Synergy Health and Fitness is an upscale fitness and personal training center located in the heart of Arlington, Virginia. At Synergy, clients are educated and motivated to seamlessly blend healthful...

The Synergy Organization

Using a scientific, evidence-based approach to achieve consistently superior results for their healthcare clients, The Synergy Organization is the country’s leading Evidence-...

More Information about "Synergy Technologies, Inc." on BioPortfolio

We have published hundreds of Synergy Technologies, Inc. news stories on BioPortfolio along with dozens of Synergy Technologies, Inc. Clinical Trials and PubMed Articles about Synergy Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synergy Technologies, Inc. Companies in our database. You can also find out about relevant Synergy Technologies, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement